Header Logo

Connection

Marilyn Kwan to Humans

Back to Details
This is a "connection" page, showing publications Marilyn Kwan has written about Humans.
Marilyn Kwan
Connection Strength
2.598
Humans
  1. Physical activity and incident cardiovascular disease in breast cancer survivors: the Pathways Study. JNCI Cancer Spectr. 2025 Jan 03; 9(1).
    View in: PubMed
    Score: 0.068
  2. Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLoS One. 2024; 19(9):e0310531.
    View in: PubMed
    Score: 0.067
  3. The Influence of Dietary Isothiocyanates on the Effectiveness of Mitomycin C and Bacillus Calmette-Gu?rin in Treating Nonmuscle-Invasive Bladder Cancer. J Urol. 2024 Sep; 212(3):420-430.
    View in: PubMed
    Score: 0.065
  4. Diet quality and cardiovascular disease risk among breast cancer survivors in the Pathways Study. JNCI Cancer Spectr. 2024 Feb 29; 8(2).
    View in: PubMed
    Score: 0.064
  5. Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study. JAMA Netw Open. 2022 11 01; 5(11):e2244430.
    View in: PubMed
    Score: 0.058
  6. Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer. Breast Cancer Res Treat. 2022 Jun; 193(3):669-675.
    View in: PubMed
    Score: 0.056
  7. Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022 May 20; 40(15):1647-1658.
    View in: PubMed
    Score: 0.056
  8. Quantifying cancer risk from exposures to medical imaging in the Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging (RIC) Study: research methods and cohort profile. Cancer Causes Control. 2022 May; 33(5):711-726.
    View in: PubMed
    Score: 0.055
  9. Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy. JAMA Netw Open. 2021 11 01; 4(11):e2133861.
    View in: PubMed
    Score: 0.055
  10. Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study. Breast Cancer Res Treat. 2020 Feb; 180(1):187-195.
    View in: PubMed
    Score: 0.048
  11. Trends in Medical Imaging During Pregnancy in the United States and Ontario, Canada, 1996 to 2016. JAMA Netw Open. 2019 07 03; 2(7):e197249.
    View in: PubMed
    Score: 0.046
  12. The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer. Cancer Causes Control. 2019 Feb; 30(2):187-193.
    View in: PubMed
    Score: 0.045
  13. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
    View in: PubMed
    Score: 0.042
  14. Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer. Cancer Causes Control. 2017 Jun; 28(6):557-562.
    View in: PubMed
    Score: 0.040
  15. Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis. Breast Cancer Res Treat. 2017 02; 161(3):501-513.
    View in: PubMed
    Score: 0.039
  16. Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study. Breast Cancer Res Treat. 2016 08; 159(1):119-29.
    View in: PubMed
    Score: 0.038
  17. Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen. Breast Cancer Res Treat. 2016 Apr; 156(2):379-89.
    View in: PubMed
    Score: 0.037
  18. RE: Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741. J Natl Cancer Inst. 2016 Jan; 108(1).
    View in: PubMed
    Score: 0.036
  19. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors. J Natl Cancer Inst. 2016 Mar; 108(3).
    View in: PubMed
    Score: 0.036
  20. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.035
  21. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
    View in: PubMed
    Score: 0.035
  22. A hybrid approach to identify subsequent breast cancer using pathology and automated health information data. Med Care. 2015 Apr; 53(4):380-5.
    View in: PubMed
    Score: 0.035
  23. Bone health history in breast cancer patients on aromatase inhibitors. PLoS One. 2014; 9(10):e111477.
    View in: PubMed
    Score: 0.034
  24. Obesity and mortality after breast cancer by race/ethnicity: The California Breast Cancer Survivorship Consortium. Am J Epidemiol. 2014 Jan 01; 179(1):95-111.
    View in: PubMed
    Score: 0.031
  25. Patient-physician interaction and quality of life in recently diagnosed breast cancer patients. Breast Cancer Res Treat. 2013 Jun; 139(2):581-95.
    View in: PubMed
    Score: 0.030
  26. Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):32-41.
    View in: PubMed
    Score: 0.029
  27. Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system. Breast Cancer Res Treat. 2012 Sep; 135(2):591-602.
    View in: PubMed
    Score: 0.029
  28. Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries. Cancer Causes Control. 2012 Sep; 23(9):1587-91.
    View in: PubMed
    Score: 0.029
  29. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012 Apr; 132(2):729-39.
    View in: PubMed
    Score: 0.028
  30. Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting. Breast Cancer Res Treat. 2012 Feb; 131(3):1029-38.
    View in: PubMed
    Score: 0.027
  31. Exercise in patients with lymphedema: a systematic review of the contemporary literature. J Cancer Surviv. 2011 Dec; 5(4):320-36.
    View in: PubMed
    Score: 0.027
  32. Change in physical activity during active treatment in a prospective study of breast cancer survivors. Breast Cancer Res Treat. 2012 Jan; 131(2):679-90.
    View in: PubMed
    Score: 0.027
  33. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011 Nov; 130(1):195-205.
    View in: PubMed
    Score: 0.026
  34. Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg. 2010 Nov; 145(11):1055-63.
    View in: PubMed
    Score: 0.025
  35. A practical method for collecting food record data in a prospective cohort study of breast cancer survivors. Am J Epidemiol. 2010 Dec 01; 172(11):1315-23.
    View in: PubMed
    Score: 0.025
  36. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
    View in: PubMed
    Score: 0.025
  37. Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010 Sep; 123(2):507-24.
    View in: PubMed
    Score: 0.024
  38. Maternal diet and risk of childhood acute lymphoblastic leukemia. Public Health Rep. 2009 Jul-Aug; 124(4):503-14.
    View in: PubMed
    Score: 0.023
  39. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res. 2009; 11(3):R31.
    View in: PubMed
    Score: 0.023
  40. Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol. 2009 Feb 20; 27(6):919-26.
    View in: PubMed
    Score: 0.022
  41. High-resolution mapping of traffic related air pollution with Google street view cars and incidence of cardiovascular events within neighborhoods in Oakland, CA. Environ Health. 2018 05 15; 17(1):38.
    View in: PubMed
    Score: 0.021
  42. The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 Dec; 19(10):1065-76.
    View in: PubMed
    Score: 0.021
  43. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008 Jun; 109(3):573-9.
    View in: PubMed
    Score: 0.020
  44. Age at Menarche and Late Adolescent Adiposity Associated with Mammographic Density on Processed Digital Mammograms in 24,840 Women. Cancer Epidemiol Biomarkers Prev. 2017 09; 26(9):1450-1458.
    View in: PubMed
    Score: 0.020
  45. Medical Conditions in the First Years of Life Associated with Future Diagnosis of ASD in Children. J Autism Dev Disord. 2017 07; 47(7):2067-2079.
    View in: PubMed
    Score: 0.020
  46. NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control. 2007 Aug; 18(6):613-20.
    View in: PubMed
    Score: 0.020
  47. Maternal illness and drug/medication use during the period surrounding pregnancy and risk of childhood leukemia among offspring. Am J Epidemiol. 2007 Jan 01; 165(1):27-35.
    View in: PubMed
    Score: 0.019
  48. Breastfeeding patterns and risk of childhood acute lymphoblastic leukaemia. Br J Cancer. 2005 Aug 08; 93(3):379-84.
    View in: PubMed
    Score: 0.018
  49. Utilization of locally estimated scatterplot smoothing (LOESS) regression to estimate missing weights in a longitudinal cohort of breast cancer patients. Ann Epidemiol. 2025 Apr; 104:55-60.
    View in: PubMed
    Score: 0.017
  50. Food consumption by children and the risk of childhood acute leukemia. Am J Epidemiol. 2004 Dec 01; 160(11):1098-107.
    View in: PubMed
    Score: 0.017
  51. Breastfeeding and the risk of childhood leukemia: a meta-analysis. Public Health Rep. 2004 Nov-Dec; 119(6):521-35.
    View in: PubMed
    Score: 0.017
  52. Social Support and Treatment Delays in Breast Cancer Patients Within an Integrated Health Care System. Psychooncology. 2024 Nov; 33(11):e70025.
    View in: PubMed
    Score: 0.017
  53. Medical imaging utilization in migrants compared with nonmigrants in a universal healthcare system: A population-based matched cohort study. PLoS Med. 2024 Oct; 21(10):e1004474.
    View in: PubMed
    Score: 0.017
  54. Trends in HR+ metastatic breast cancer survival before and after CDK4/6 inhibitor introduction in the United States: a SEER registry analysis of patients with HER2- and HER2+ metastatic breast cancer. Breast Cancer Res Treat. 2024 Nov; 208(2):223-235.
    View in: PubMed
    Score: 0.017
  55. The standard oxygen consumption value equivalent to one metabolic equivalent (3.5 ml/min/kg) is not appropriate for elderly people. Int J Food Sci Nutr. 2004 May; 55(3):179-82.
    View in: PubMed
    Score: 0.016
  56. Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast Cancer. JAMA Netw Open. 2024 Mar 04; 7(3):e243345.
    View in: PubMed
    Score: 0.016
  57. Risk of adverse birth outcomes after adolescent and young adult cancer. JNCI Cancer Spectr. 2024 Jan 04; 8(1).
    View in: PubMed
    Score: 0.016
  58. Medical imaging utilization and associated radiation exposure in children with down syndrome. PLoS One. 2023; 18(9):e0289957.
    View in: PubMed
    Score: 0.015
  59. Associations of Post-Diagnosis Lifestyle with Prognosis in Women with Invasive Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2023 07 05; 32(7):963-975.
    View in: PubMed
    Score: 0.015
  60. A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study. Cancer Res Commun. 2023 06; 3(6):1104-1112.
    View in: PubMed
    Score: 0.015
  61. Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Res Treat. 2023 Aug; 201(1):117-126.
    View in: PubMed
    Score: 0.015
  62. Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways Study. Cancer. 2023 08 01; 129(15):2395-2408.
    View in: PubMed
    Score: 0.015
  63. Associations of dietary isothiocyanate exposure from cruciferous vegetable consumption with recurrence and progression of non-muscle-invasive bladder cancer: findings from the Be-Well Study. Am J Clin Nutr. 2023 06; 117(6):1110-1120.
    View in: PubMed
    Score: 0.015
  64. Plant-Based Dietary Patterns and Breast Cancer Recurrence and Survival in the Pathways Study. Nutrients. 2021 Sep 25; 13(10).
    View in: PubMed
    Score: 0.014
  65. Weight stability masks changes in body composition in colorectal cancer: a retrospective cohort study. Am J Clin Nutr. 2021 06 01; 113(6):1482-1489.
    View in: PubMed
    Score: 0.013
  66. "I Had to Make Them Feel at Ease": Narrative Accounts of How Women With Breast Cancer Navigate Social Support. Qual Health Res. 2021 05; 31(6):1056-1068.
    View in: PubMed
    Score: 0.013
  67. Trends in Imaging for Suspected Pulmonary Embolism Across US Health Care Systems, 2004 to 2016. JAMA Netw Open. 2020 11 02; 3(11):e2026930.
    View in: PubMed
    Score: 0.013
  68. History of Early Childhood Infections and Acute Lymphoblastic Leukemia Risk Among Children in a US Integrated Health-Care System. Am J Epidemiol. 2020 10 01; 189(10):1076-1085.
    View in: PubMed
    Score: 0.013
  69. Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery. JAMA Surg. 2020 10 01; 155(10):942-949.
    View in: PubMed
    Score: 0.013
  70. Hospital Characteristics and Breast Cancer Survival in the California Breast Cancer Survivorship Consortium. JCO Oncol Pract. 2020 06; 16(6):e517-e528.
    View in: PubMed
    Score: 0.012
  71. Distinct trajectories of moderate to vigorous physical activity and sedentary behavior following a breast cancer diagnosis: the Pathways Study. J Cancer Surviv. 2020 06; 14(3):393-403.
    View in: PubMed
    Score: 0.012
  72. The effect of multiple recruitment contacts on response rates and patterns of missing data in a survey of bladder cancer survivors 6 months after cystectomy. Qual Life Res. 2020 Apr; 29(4):879-889.
    View in: PubMed
    Score: 0.012
  73. A Scalable Database of Organ Doses for Common Diagnostic Fluoroscopy Procedures of Children: Procedures of Historical Practice for Use in Radiation Epidemiology Studies. Radiat Res. 2019 12; 192(6):649-661.
    View in: PubMed
    Score: 0.012
  74. Distinct trajectories of fruits and vegetables, dietary fat, and alcohol intake following a breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2020 Jan; 179(1):229-240.
    View in: PubMed
    Score: 0.012
  75. Trends in Use of Medical Imaging in US Health Care Systems and in Ontario, Canada, 2000-2016. JAMA. 2019 09 03; 322(9):843-856.
    View in: PubMed
    Score: 0.012
  76. Decision Regret Related to Urinary Diversion Choice among Patients Treated with Cystectomy. J Urol. 2020 01; 203(1):159-163.
    View in: PubMed
    Score: 0.012
  77. Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Breast Cancer Res Treat. 2018 Aug; 170(3):623-631.
    View in: PubMed
    Score: 0.011
  78. Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient-provider interactions. Breast Cancer Res Treat. 2018 Aug; 170(3):593-603.
    View in: PubMed
    Score: 0.011
  79. Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 09; 26(9):1466-1469.
    View in: PubMed
    Score: 0.010
  80. Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev. 2017 07; 26(7):1008-1015.
    View in: PubMed
    Score: 0.010
  81. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017 Jul 01; 123(13):2535-2542.
    View in: PubMed
    Score: 0.010
  82. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study. JAMA Oncol. 2017 Mar 01; 3(3):351-357.
    View in: PubMed
    Score: 0.010
  83. Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors. Breast Cancer Res Treat. 2017 04; 162(3):549-557.
    View in: PubMed
    Score: 0.010
  84. Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 04; 26(4):505-515.
    View in: PubMed
    Score: 0.010
  85. Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):30-37.
    View in: PubMed
    Score: 0.010
  86. Postdiagnosis social networks and breast cancer mortality in the After Breast Cancer Pooling Project. Cancer. 2017 Apr 01; 123(7):1228-1237.
    View in: PubMed
    Score: 0.010
  87. BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study. J Natl Cancer Inst. 2017 02; 109(2).
    View in: PubMed
    Score: 0.010
  88. Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams. JAMA Oncol. 2016 Sep 01; 2(9):1137-45.
    View in: PubMed
    Score: 0.010
  89. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study. JAMA Oncol. 2016 Sep 01; 2(9):1170-6.
    View in: PubMed
    Score: 0.010
  90. Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies. Cancer Res. 2016 09 15; 76(18):5415-22.
    View in: PubMed
    Score: 0.009
  91. Dual energy X-ray absorptiometry spine scans to determine abdominal fat in postmenopausal women. Am J Hum Biol. 2016 11; 28(6):918-926.
    View in: PubMed
    Score: 0.009
  92. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016 08 10; 34(23):2743-9.
    View in: PubMed
    Score: 0.009
  93. The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality. Cancer Epidemiol Biomarkers Prev. 2016 07; 25(7):1064-72.
    View in: PubMed
    Score: 0.009
  94. Impact of very low physical activity, BMI, and comorbidities on mortality among breast cancer survivors. Breast Cancer Res Treat. 2016 Feb; 155(3):551-7.
    View in: PubMed
    Score: 0.009
  95. Who Gets to Decide? Radiology. 2016 Feb; 278(2):635-6.
    View in: PubMed
    Score: 0.009
  96. Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Causes Control. 2016 Mar; 27(3):391-401.
    View in: PubMed
    Score: 0.009
  97. Post-diagnosis social networks, and lifestyle and treatment factors in the After Breast Cancer Pooling Project. Psychooncology. 2017 04; 26(4):544-552.
    View in: PubMed
    Score: 0.009
  98. A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis. Int J Cancer. 2016 May 01; 138(9):2088-97.
    View in: PubMed
    Score: 0.009
  99. Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer. J Community Health. 2015 Dec; 40(6):1287-99.
    View in: PubMed
    Score: 0.009
  100. Representativeness of breast cancer cases in an integrated health care delivery system. BMC Cancer. 2015 Oct 14; 15:688.
    View in: PubMed
    Score: 0.009
  101. Contribution of the neighborhood environment and obesity to breast cancer survival: the California Breast Cancer Survivorship Consortium. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1282-90.
    View in: PubMed
    Score: 0.009
  102. The impact of DNA input amount and DNA source on the performance of whole-exome sequencing in cancer epidemiology. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1207-13.
    View in: PubMed
    Score: 0.009
  103. History of Recreational Physical Activity and Survival After Breast Cancer: The California Breast Cancer Survivorship Consortium. Am J Epidemiol. 2015 Jun 15; 181(12):944-55.
    View in: PubMed
    Score: 0.009
  104. Statins and breast cancer stage and mortality in the Women's Health Initiative. Cancer Causes Control. 2015 Apr; 26(4):529-39.
    View in: PubMed
    Score: 0.009
  105. Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiol Biomarkers Prev. 2015 Feb; 24(2):361-8.
    View in: PubMed
    Score: 0.008
  106. Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study. BMC Cancer. 2014 May 29; 14:382.
    View in: PubMed
    Score: 0.008
  107. Pre- to post-diagnosis weight change and associations with physical functional limitations in breast cancer survivors. J Cancer Surviv. 2014 Dec; 8(4):539-47.
    View in: PubMed
    Score: 0.008
  108. Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
    View in: PubMed
    Score: 0.008
  109. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):714-24.
    View in: PubMed
    Score: 0.008
  110. Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
    View in: PubMed
    Score: 0.008
  111. The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. Cancer Causes Control. 2013 Oct; 24(10):1821-36.
    View in: PubMed
    Score: 0.008
  112. Postdiagnosis cruciferous vegetable consumption and breast cancer outcomes: a report from the After Breast Cancer Pooling Project. Cancer Epidemiol Biomarkers Prev. 2013 Aug; 22(8):1451-6.
    View in: PubMed
    Score: 0.008
  113. Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2013 Jun; 139(2):529-37.
    View in: PubMed
    Score: 0.008
  114. Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Res Treat. 2013 Jun; 139(2):515-27.
    View in: PubMed
    Score: 0.008
  115. High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. J Natl Cancer Inst. 2013 May 01; 105(9):616-23.
    View in: PubMed
    Score: 0.007
  116. The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis. Sci Rep. 2013; 3:2246.
    View in: PubMed
    Score: 0.007
  117. The molecular and clinicopathologic characteristics of bilateral breast cancer. Sci Rep. 2013; 3:2590.
    View in: PubMed
    Score: 0.007
  118. Social networks, social support, and burden in relationships, and mortality after breast cancer diagnosis in the Life After Breast Cancer Epidemiology (LACE) study. Breast Cancer Res Treat. 2013 Jan; 137(1):261-71.
    View in: PubMed
    Score: 0.007
  119. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov; 136(2):521-33.
    View in: PubMed
    Score: 0.007
  120. Employment status and quality of life in recently diagnosed breast cancer survivors. Psychooncology. 2013 Jun; 22(6):1411-20.
    View in: PubMed
    Score: 0.007
  121. Identifying primary and recurrent cancers using a SAS-based natural language processing algorithm. J Am Med Inform Assoc. 2013 Mar-Apr; 20(2):349-55.
    View in: PubMed
    Score: 0.007
  122. Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2012 Aug; 21(8):1260-71.
    View in: PubMed
    Score: 0.007
  123. Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr. 2012 Jul; 96(1):123-32.
    View in: PubMed
    Score: 0.007
  124. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1115-25.
    View in: PubMed
    Score: 0.007
  125. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer. 2012 Apr 15; 118(8):2048-58.
    View in: PubMed
    Score: 0.007
  126. Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project. Breast Cancer Res Treat. 2012 Jan; 131(2):637-43.
    View in: PubMed
    Score: 0.007
  127. The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics. Cancer Causes Control. 2011 Sep; 22(9):1319-31.
    View in: PubMed
    Score: 0.007
  128. Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study. Breast Cancer Res Treat. 2011 Sep; 129(2):521-9.
    View in: PubMed
    Score: 0.007
  129. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011 Apr; 126(2):529-37.
    View in: PubMed
    Score: 0.006
  130. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet. 2010 Jul 29; 6(7):e1001043.
    View in: PubMed
    Score: 0.006
  131. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2009 Nov; 118(2):395-405.
    View in: PubMed
    Score: 0.006
  132. Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease. Am J Surg Pathol. 2009 Feb; 33(2):256-63.
    View in: PubMed
    Score: 0.006
  133. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2009 Oct; 117(3):653-65.
    View in: PubMed
    Score: 0.006
  134. Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):87-95.
    View in: PubMed
    Score: 0.006
  135. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control. 2008 Dec; 19(10):1319-28.
    View in: PubMed
    Score: 0.005
  136. Lifestyle factors and survival in women with breast cancer. J Nutr. 2007 01; 137(1 Suppl):236S-242S.
    View in: PubMed
    Score: 0.005
  137. Environmental and genetic risk factors for childhood leukemia: appraising the evidence. Cancer Invest. 2005; 23(1):60-75.
    View in: PubMed
    Score: 0.004
  138. Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma. Cancer Res. 1988 Aug 01; 48(15):4307-11.
    View in: PubMed
    Score: 0.001

© 2025 Kaiser Permanente

Your Privacy Choices